BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Taisho Pharmaceutical Co., Inc. 

24-1, Takada 3-Chome

Toshima-ku  Tokyo  170-8633  Japan
Phone: 81-0-3-39851111 Fax: 81-0-3-39858627


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

Merck & Co., Inc.  Neuroscience

Pharmagene Laboratories Limited 





 Company News
Taisho Pharmaceutical Leads Bids For India's Paras Pharmaceuticals Ltd. 10/6/2010 7:54:24 AM
Bristol-Myers Squibb Company (BMY) (JOBS) Sells Asia Rights to Japan's Taisho Pharmaceutical for $310 Million 9/16/2009 7:02:01 AM
Chugai Pharmaceutical Co., Ltd. (Japan) and Taisho Pharmaceutical Release: Eldecalcitol, an Active Vitamin D3 Derivative, Reduces Incidence of New Vertebral Fractures in Osteoporosis Patients in Phase III Clinical Trial 12/18/2008 8:49:44 AM
Pfizer Inc. (PFE) and Taisho Pharmaceutical Finalize Deal on Schizophrenia Drug; Pfizer to Pay Initial $22M 1/7/2008 6:21:24 AM
Pfizer Inc. (PFE) Signs Deal for Taisho Pharmaceutical's Schizophrenia Drug 10/30/2007 7:08:55 AM
BrainCells Inc. and Taisho Pharmaceutical Sign Licensing Agreement for Novel CNS Program 9/27/2007 7:41:23 AM
Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries, Ltd. and Taisho Pharmaceutical 6/1/2007 11:07:44 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Announces Co-Development And Co-Marketing Agreement With Taisho Pharmaceutical For The Antiresorptive Bisphosphonate R484 9/12/2006 2:12:37 PM
The Day In Review: Immunicon Corporation (IMMC) Rises On AstraZeneca PLC (AZN) Deal 8/7/2006 5:02:04 PM
Taisho Pharmaceutical And Eli Lilly and Company (LLY) Terminate A License Agreement For Taisho's Potential New Drug For Treatment Of Type 2 Diabetes 8/7/2006 10:37:41 AM
123